文献速递冠心病外科瓣膜外科

冠状动脉旁路移植术联合或不联合二尖瓣修复治疗中度缺血性二尖瓣反流的生存分析

Survival After Coronary Artery Bypass Grafting With or Without Mitral Valve Repair for Moderate Ischemic Mitral Regurgitation.
PubMed 文献 · Ann Thorac Surg · 2026-03-19

该回顾性队列纳入650例中度缺血性二尖瓣反流行单纯冠状动脉旁路移植术(CABG,n=493)或CABG联合二尖瓣修复(n=157)的患者,采用逆概率治疗加权调整基线差异。中位随访36.6个月,联合修复组全因死亡风险更低(多变量风险比0.41,95%CI 0.22-0.79;

要点

  • 中度缺血性二尖瓣反流患者CABG联合二尖瓣修复与更低全因死亡风险相关(HR 0.41,95%CI 0.22-0.79)。
  • 联合修复组二尖瓣反流改善率更高(75.4% vs 50.4%),但术后插管和ICU停留更长、急性肾损伤风险增加。

核心结论

  • 在亚洲真实世界队列中,CABG联合二尖瓣修复治疗中度缺血性二尖瓣反流与更低全因死亡和复合心脑血管事件相关,但围术期并发症增加。

研究设计与样本

  • 回顾性分析2009年8月至2024年4月650例中度缺血性二尖瓣反流患者,单纯CABG 493例,CABG联合二尖瓣修复157例,采用逆概率治疗加权调整基线差异。

主要发现

  • 联合修复组术后插管和ICU停留更长、急性肾损伤风险增加,但早期死亡率未增加。

临床怎么用

  • 对中度缺血性二尖瓣反流行CABG的患者,可考虑同期二尖瓣修复以降低远期死亡和心衰再入院风险。
  • 决策时需权衡联合修复带来的围术期急性肾损伤和ICU资源占用增加。

局限性

  • 回顾性设计,即使采用逆概率治疗加权仍可能存在未测量混杂。
  • 为单中心亚洲人群真实世界队列,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The surgical management of moderate ischemic mitral regurgitation (IMR) in patients undergoing coronary artery bypass grafting (CABG) remains controversial, with limited real-world evidence, particularly from Asian populations. METHODS: We retrospectively analyzed 650 patients with moderate IMR who underwent isolated CABG (n = 493) or CABG with mitral valve repair (n = 157) between August 2009 and April 2024. Inverse probability of treatment weighting was applied to adjust for baseline differences. The primary end point was all-cause mortality; the secondary end point was major adverse cardiovascular and cerebrovascular events. RESULTS: During a median follow-up of 36.6 months, CABG with mitral valve repair was associated with lower all-cause mortality (multivariable hazard ratio, 0.41; 95% CI, 0.22-0.79; weighted log-rank P = .006) and fewer composite events (weighted log-rank P = .001), mainly driven by fewer deaths and rehospitalizations for heart failure. Findings were consistent across sensitivity and subgroup analyses. Echocardiographic follow-up (median, 11.6 months) showed greater improvement in mitral regurgitation (75.4% vs 50.4%; P < .001) and a larger reduction in left ventricular end-diastolic diameter (4.0 [0-7.8] mm vs 3.0 [-1.0 to 6.0] mm; P = .026). CABG with repair was associated with longer postoperative intubation, intensive care unit stay, and increased risk of acute kidney injury, without increased early mortality. CONCLUSIONS: In one of the largest Asian real-world cohorts, concomitant mitral valve repair during CABG for moderate IMR was associated with lower mortality and fewer major adverse cardiovascular and cerebrovascular events and greater echocardiographic improvement but at the expense of increased perioperative morbidity.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Chen L, Tiemuerniyazi X, Yang Z, et al. Survival After Coronary Artery Bypass Grafting With or Without Mitral Valve Repair for Moderate Ischemic Mitral Regurgitation. Ann Thorac Surg. 2026. PMID: 41864531. doi:10.1016/j.athoracsur.2026.03.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。